HPV vaccine uptake after introduction of the vaccine in Germany: An analysis of administrative data

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 6, 2014, Pages 1729-1733

  Hense, Sabrina ^a   Hillebrand, Kathrin ^a   Horn, Johannes ^b   Mikolajczyk, Rafael ^b   Schulze Rath, Renate ^c,d   Garbe, Edeltraut ^a,e  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c Sanofi Pasteur MSD GmbH   (Germany)

^d BAYER PHARMA AG   (Germany)

^e UNIVERSITY OF BREMEN   (Germany)

Author keywords

Claims data; Females; Human papilloma virus; Uptake; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; DRUG INDICATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HEALTH INSURANCE ELIGIBILITY; HUMAN; OUTPATIENT CARE; REIMBURSEMENT; SCHOOL CHILD; VACCINATION; WOMEN'S HEALTH; YOUNG ADULT; AGE; PAPILLOMAVIRUS INFECTIONS; UTILIZATION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; FEMALE; GERMANY; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VACCINATION; YOUNG ADULT;

EID: 84905648790     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28450     Document Type: Article

References (31)

1. Günther OP, Ogilvie G, Naus M, Young E, Patrick DM, Dobson S, Duval B, Noël PA, Marra F, Miller D, et al. Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity? J Infect Dis 2008; 197:1653-61; PMID:18513154; http://dx.doi.org/10.1086/588140
2. Siedler A, Rieck T, Reuss A, Walter D, Poggensee G, Poethko-Muller C, Reiter S. Estimating vaccination coverage in the absence of immunisation registers - the German experience. Euro Surveill 2012; 17:20152; PMID:22551497
3. Blödt S, Holmberg C, Müller-Nordhorn J, Rieckmann N. Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health 2012; 22:808-13; PMID:22199161; http://dx.doi.org/10.1093/eurpub/ ckr188
4. Deleré Y, Böhmer MM, Walter D, Wichmann O. HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey. Hum Vaccin Immunother 2013; 9:1706-11; PMID:23732901; http://dx.doi.org/10.4161/hv.24904
5. Samkange-Zeeb F, Spallek L, Klug SJ, Zeeb H. HPV infection awareness and self-reported HPV vaccination coverage in female adolescent students in two German cities. J Community Health 2012; 37:1151-6; PMID:22772842; http://dx.doi.org/10.1007/s10900-012-9589-1
6. Murray CJ, Shengelia B, Gupta N, Moussavi S, Tandon A, Thieren M. Validity of reported vaccination coverage in 45 countries. Lancet 2003; 362:1022-7; PMID:14522532; http://dx.doi.org/10.1016/S0140-6736(03)14411-X
7. Stöcker P, Dehnert M, Schuster M, Wichmann O, Deleré Y. Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Hum Vaccin Immunother 2013; 9:74-82; PMID:22995838; http://dx.doi.org/10.4161/hv.22192
8. Garbe E, Suling M, Kloss S, Lindemann C, Schmid U. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 2011; 20:258-64; PMID:21351307; http://dx.doi.org/10. 1002/pds.2038; http://dx.doi.org/10.1002/pds.2038
9. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis 2010; 10:360; PMID:21182757; http://dx.doi.org/10.1186/1471-2334-10-360
10. Kraut AA, Langner I, Lindemann C, Banaschewski T, Petermann U, Petermann F, Mikolajczyk RT, Garbe E. Comorbidities in ADHD children treated with methylphenidate: a database study. BMC Psychiatry 20131311 PMID:23294623http:// dx.doi.org/10.1186/1471-244X-13-11
11. Lindemann C, Langner I, Kraut AA, Banaschewski T, Schad-Hansjosten T, Petermann U, Petermann F, Schreyer-Mehlhop I, Garbe E, Mikolajczyk RT. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 2012; 22:307-14; PMID:22856384; http://dx.doi.org/10.1089/cap. 2011.0064
12. Pigeot I, Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf20081721523 PMID:18200610http://dx.doi. org/10.1002/pds.1545
13. WildF2011. [cited 2013 August 28]. Available from: http://www.wip-pkv.de/ uploads/tx-nppresscenter/HPV-Impfung.pdf
14. Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, Velonakis EG. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake. Vaccine 2012; 30:6967-70; PMID:23022147; http://dx.doi.org/10.1016/j.vaccine.2012.09.028
15. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O'Flanagan D, Lopalco PL, D'Ancona F, Levy-Bruhl D; VENICE 2 project gatekeepers group. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010; 15:19730; PMID:21144444
16. Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 2013; 119:1386-92; PMID:23508594; http://dx.doi.org/10.1002/cncr. 27894
17. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105:175-201; PMID:23297039; http://dx.doi.org/10.1093/ jnci/djs491
18. Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep 2013; 62:591-5; PMID:23884346
19. Hull B, Dey A, Mahajan D, Campbell-Lloyd S, Menzies RI, McIntyre PB. NSW annual immunisation coverage report, 2009. N S W Public Health Bull 2010; 21:210-23; PMID:21211474; http://dx.doi.org/10.1071/NB10045
20. Hull B, Dey A, Campbell-Lloyd S, Menzies RI, McIntyre PB. NSW annual immunisation coverage report, 2010. N S W Public Health Bull 2011; 22:179-95; PMID:22060056; http://dx.doi.org/10.1071/NB11021
21. Hull B, Dey A, Campbell-Lloyd S, Menzies RI, McIntyre PB. NSW annual immunisation coverage report, 2011. N S W Public Health Bull 2012; 23:179-86; PMID:23442995; http://dx.doi.org/10.1071/NB12084
22. Mak DB, Bulsara MK, Wrate MJ, Carcione D, Chantry M, Ef ller PV. Factors determining vaccine uptake in Western Australian adolescents. J Paediatr Child Health 2013; 49:895-900; http://dx.doi.org/10.1111/jpc.12030; PMID:23198962
23. Ward KF, Menzies RI, Quinn HE, Campbell-Lloyd S. School-based vaccination in NSW. N S W Public Health Bull 2010; 21:237-42; PMID:21211477; http://dx.doi.org/10.1071/NB10046
24. der Privaten KrankenversicherungenV2012. [cited 2013 Oct 24] Available from: http://www.pkv.de/service/zahlen-und-fakten/archiv-pkv-zahlenbericht/ zahlenbericht-2011-2012.pdf.
25. Horn J, Damm O, Kretzschmar ME, Deleré Y, Wichmann O, Kaufmann AM, Garbe E, Krämer A, Greiner W, Mikolajczyk RT. Estimating the long-term effects of HPV vaccination in Germany. Vaccine 2013; 31:2372-80; PMID:23518405; http://dx.doi.org/10.1016/j.vaccine.2013.03.006
26. European Centre for Disease Prevention and Control. Introduction of HPV vaccines in European Union countries - an update. 2012. Stockholm, ECDC.
27. Mehu-Parant F, Rouzier R, Soulat JM, Parant O. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. Eur J Obstet Gynecol Reprod Biol 2010; 148:186-90; PMID:19926199; http://dx.doi.org/10.1016/j.ejogrb.2009.10.024
28. Schwabe U, Paffrath D., Arzneiverordnungreport 2008. Springer, Berlin. 2009.
29. Garcini LM, Galvan T, Barnack-Tavlaris JL. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine 2012; 30:4588-95; PMID:22579865; http://dx.doi.org/10.1016/j.vaccine.2012.04.096
30. Schink T, Garbe E. Assessment of the representativity of in-patient hospital diagnoses in the German Pharmacoepidemiological Research Database. Kongress "Individualisierte Prävention und Epidemiologie: Die moderne Medizin". Gesundheitswesen20107210 http://dx.doi.org/10.1055/s-0030-1266518
31. Schink T, Garbe E. Representativity of dispensations of non-steroidal anti-inf lammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database. Kongress "Individualisierte Prävention und Epidemiologie: Die moderne Medizin".Gesundheitswesen201072V111http://dx.doi.org/10.1055/s- 0030-1266287